Park West Asset Management LLC Galmed Pharmaceuticals Ltd. Transaction History

Park West Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.04 - $17.96 $1.83 Million - $6.53 Million	-363,700 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.12 - $11.77 $362,767 - $833,939	70,853 Added 24.19%	363,700 $2.03 Million
Q4 2017 Feb 14, 2018	BUY	$6.78 - $9.32 $83,712 - $115,074	12,347 Added 4.4%	292,847 $2.68 Million
Q3 2017 Nov 14, 2017	BUY	$7.36 - $9.29 $2.06 Million - $2.61 Million	280,500	280,500 $2.56 Million

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $67.7M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Park West Asset Management LLC with notifications on news.